Abstract:Abstract Background: Osteoclasts are large terminal-differentiated cells with multiple nuclei and are the only cells with bone resorption activity in the body. The abnormal migration and differentiation of osteoclasts may accelerate bone absorption, a crucial process in the occurrence and development of osteoporosis. Regulating the differentiation and activation of osteoclasts is a breakthrough point for the prevention and treatment of osteoporosis. Coumarin derivative of 3-(4-methoxyl)-1-(2-(4-coumarin) prop)-2-en-1-one (MCPEO) was selected in this study. We aimed to investigate the effects of (MCPEO) on osteoclast differentiation. Methods: Bone marrow mononuclear cells (BM-MNCs) were collected from 6-week-old ICR mice and inoculated in vitro. BM-MNC and RAW264.7 cells were induced by the receptor activator of nuclear factor κ B ligand (RANKL) to differentiate them into osteoclasts. The cells were then added with 0.01, 0.05, 0.1, 0.5, and 1 μM MCPEO. The cell viability of differentiated osteoclasts was analyzed by methylthiazolyldiphenyl-tetrazolium bromide assay. The differentiated osteoclasts were detected by tartrate-resistant acid phosphatase (TRAP) staining. Miuse osteoclast activation was investigated by absorptive activity analysis. Filamentous actin (F-actin) staining was employed to identify the formation of F-actin rings in the differentiated mouse osteoclasts. The change level of critical transcription factors related to osteoclast differentiation was determined by Western blot analysis. Results: Data show that MCPEO affected the cell viability of differentiated osteoclasts, inhibited the formation of TRAP-positive polynuclear cells, and decreased the absorption activity and the formation of F-actin rings in the differentiated osteoclasts. Furthermore, MCPEO influenced the change level of crucial transcription factors related to osteoclast differentiation. Conclusions: MCPEO inhibited the differentiation of RANKL-induced BM-MNC and RAW264.7 cells into osteoclasts.

Effects of Berberine on Differentiation and Bone Resorption of Osteoclasts Derived from Rat Bone Marrow Cells

[Effect of the Bone Resorption Supernatant from RAW264.7 Osteoclast on the Osteogenic Activity of Mouse MC3T3-E1 Cell].

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways.

Protective effects of berberine in an experimental rat osteoarthritis model.

Effects of Rubiadin from Morinda officinalis on Osteoclastic Bone Resorption

Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss

Effects of Berberine from Cortex Phellodendri Chinensis on Osteoporosis in Ovariectomized Rats

[Berberine Promotes Osteogenic Differentiation of Rat Adipose-Derived Stem Cells Through JNK Signaling Pathway].

Inhibitory Effect and Cell Mechanism of BM_(210955) on Bone Resorption

Application of Cell Engineering of Herbal Medicine Treating Bone Resorption of Osteoclasts

Effect of Trans-resveratrol on the Differentiation of Osteoclast Induced from Bone Marrow in Mice

Berberine promotes osteogenic differentiation of mesenchymal stem cells with therapeutic potential in periodontal regeneration

Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption.

3-(4-Methoxyl)-1-(2-(4-coumarin)prop)-2-en-1-one Inhibits the Differentiation of Osteoclasts

Dual effects of baicalin on osteoclast differentiation and bone resorption.

Effects of Berberine on Human Omental Preadipocyte Proliferation and Differentiation

Effect of genistein on osteoclastic bone resorption and its mechanism

Effect of icariin and curculigoside on inhibition of osteoclastic formation,differentiation and bone absorption

The Effect of Lycopene on the Differentiation of Osteoclast Induced from Bone Marrow in Mice

[Effect of berberine on the differentiation of adipocyte].

Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine: Insights into the RANKL/NF-κB signaling pathway